Sort
82,697 grants matching “vaccine development”
Core 3 - Immunobiology Core
$1,232,994Derek Wilson Cain · Duke University · U54 · FY2022 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$1,232,898Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$1,232,563Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2011 · RR
Establishment/Maintenance of Biomedical Research Colony
$1,232,563Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2011 · RR
Antigenicity and Immunogenicity of Stabilized prefusion F protein
$1,232,506Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Task 11 (D16): In Vitro and Animal Models for Emerging Diseases and Biodefense
$1,232,482Lovelace Biomedical & Environmental Research Institute · N01 · FY2009 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,232,245Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Therapeutics for Pox, Filo and Other Viral Pathogens
$1,231,876Stewart W. Schneller · Auburn University At Auburn · U19 · FY2006 · AI
iPS cell based immunotherapy for malignant gliomas
$1,231,643John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,231,558Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
NIDA Clinical Trials Network: Greater New York Node
$1,231,502John P Rotrosen · New York University School Of Medicine · UG1 · FY2017 · DA
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$1,231,345Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
$1,231,309Cynthia Ann Derdeyn · Emory University · R01 · FY2017 · AI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,231,207Adriana H Tremoulet · University Of California, San Diego · P50 · FY2024 · HD
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
$1,231,164Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2025 · AI
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
$1,230,985Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2014 · AI
The Danger Model 2: how tissues control Immunity
$1,230,903Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Task C9: Production and distribution of Filarial Research Reagents
$1,230,541Andrew Moorhead · University Of Georgia · N01 · FY2020 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,230,515Pablo Tebas · University Of Pennsylvania · UM1 · FY2016 · AI
Pathogenesis Of Enteric Viral Hepatitis
$1,230,287Robert H. Purcell · Niaid Extramural Activities · Z01 · FY2007 · AI
Therapeutics for Pox, Filo and Other Viral Pathogens
$1,229,995Stewart W. Schneller · Auburn University At Auburn · U19 · FY2007 · AI
Harvard Tanzania HIV/AIDS Clinical Trials Unit
$1,229,815Wafaie W Fawzi · Harvard School Of Public Health · U01 · FY2009 · AI
Directing Tumor-specific T cells to Tumors
$1,229,591Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA